Keyphrases
Chemotherapy
67%
Chemotherapy-induced
41%
Systematic Meta-analysis
39%
Doxorubicin
39%
Meta-analysis
36%
Vascular Toxicity
30%
Cancer Patients
29%
Fertility Preservation
28%
Malignancy
27%
Breast Cancer Patients
24%
Calpain
24%
Testicular Toxicity
21%
Cisplatin
21%
COVID-19
20%
Ovarian Toxicity
20%
Cancer Treatment
20%
Israel
19%
Young Patients
19%
Ovarian Reserve
18%
Tumor
18%
Anti-Mllerian Hormone
18%
Hazard Ratio
17%
Patients with Cancer
17%
Gastrointestinal Cancer
17%
Gastrointestinal Tract Cancer
16%
Esophageal Cancer
16%
Phase II Trial
16%
Early Onset
16%
High Risk
16%
Overall Survival
16%
Confidence Interval
16%
Chemotherapy-induced Ovarian Failure
14%
Colorectal Cancer
14%
Breast Cancer
14%
Breast Cancer Susceptibility Gene 1 (BRCA1)
14%
Recurrence Score
13%
In Cancer
13%
Placebo
12%
Oncotype DX
12%
Oxaliplatin
12%
Gonadotropin-releasing Hormone
12%
BRCA1, BRCA2
12%
Cancer-related
12%
Neoadjuvant Therapy
12%
Meta-analysis of Randomized Controlled Trials
12%
Cyclophosphamide
12%
Pediatric
11%
Trastuzumab
11%
Risk Ratio
11%
Apoptosis
11%
Medicine and Dentistry
Malignant Neoplasm
85%
Breast Cancer
51%
Neoplasm
34%
Cancer
33%
Colorectal Cancer
31%
Fertility Preservation
28%
Oocyte
26%
Gastrointestinal Cancer
23%
Recurrent Disease
23%
Doxorubicin
22%
COVID-19
21%
Ovarian Reserve
21%
Cancer Treatment
19%
Adverse Event
17%
Programmed Cell Death
17%
Systematic Review
16%
Meta-Analysis
16%
Stomach Cancer
16%
Neoadjuvant Therapy
16%
Hormone Determination
16%
Oncology
15%
Disease
15%
Muellerian Inhibiting Factor
15%
Ovary Insufficiency
15%
Vascularity
15%
Metastatic Carcinoma
14%
Overall Survival
14%
Placebo
14%
Symptom
14%
Immunotherapy
14%
Diarrhea
13%
Blood Flow
13%
Radiation Therapy
12%
Esophageal Cancer
12%
Oxaliplatin
12%
Pediatrics
12%
Oncotype DX
11%
Gold Nanoparticle
11%
Aromatase Inhibitor
11%
Prostate Cancer
11%
Retrospective Study
11%
Gastrointestinal Tract
11%
Rotavirus
11%
Pembrolizumab
11%
Heat Shock Transcription Factor 1
11%
Colon Cancer
11%
Adenocarcinoma
11%
Biological Marker
10%
Squamous Cell Carcinoma
9%
Esophageal Adenocarcinoma
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Malignant Neoplasm
78%
Breast Cancer
48%
Mouse
35%
Doxorubicin
29%
Colorectal Cancer
26%
Calpain
22%
Stomach Cancer
22%
Cisplatin
21%
Disease
19%
Neoplasm
19%
Overall Survival
18%
Randomized Controlled Trial
17%
Recurrent Disease
15%
Ovary Insufficiency
15%
Diarrhea
14%
Adverse Event
14%
Oxaliplatin
13%
Digestive System Cancer
12%
Chemoradiation Therapy
11%
Cyclophosphamide
11%
Dyspnea
11%
Docetaxel
11%
Calpastatin
11%
Rotavirus
11%
Colon Cancer
11%
Immunotherapy
11%
Epidermal Growth Factor Receptor
10%
Placebo
9%
Trastuzumab
9%
Gonadorelin Antagonist
9%
Metastasis
8%
Disease Free Survival
8%
Symptom
8%
Rotavirus Vaccine
8%
Blood Vessel Injury
8%
Gonadorelin Agonist
7%
Adenocarcinoma
7%
Pancreas Cancer
7%
Survival Rate
7%
Follitropin
7%
Biological Marker
7%
Busulfan
7%
Cetuximab
6%
Tumor Growth
6%
Toxicity
6%
Low Molecular Weight Heparin
6%
Head and Neck Cancer
6%
Squamous Cell Carcinoma
6%
Taxane
6%